{"id":1353,"date":"2021-01-21T16:22:25","date_gmt":"2021-01-21T15:22:25","guid":{"rendered":"https:\/\/www.taleaspa.com\/investor-relations\/calendario-finanziario-2021\/"},"modified":"2023-02-10T12:46:13","modified_gmt":"2023-02-10T11:46:13","slug":"financial-calendar-2021","status":"publish","type":"page","link":"https:\/\/taleagroupspa.com\/en\/investor-relations\/financial-calendar-2021\/","title":{"rendered":"Financial Calendar 2021"},"content":{"rendered":"

[vc_row][vc_column][vc_column_text]

Last update: 30 March 2026<\/div>[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”3\/4″ offset=”vc_col-xs-9″][vc_column_text]BoD to approve revenue figures and main KPIs for Q4 2020, unaudited[\/vc_column_text][\/vc_column][vc_column width=”1\/4″ offset=”vc_col-xs-3″ el_class=”c-807667″][vc_column_text]29\/01\/2021[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”3\/4″ offset=”vc_col-xs-9″][vc_column_text]BoD to approve the draft Financial Statements as at 31\/12\/2020[\/vc_column_text][\/vc_column][vc_column width=”1\/4″ offset=”vc_col-xs-3″ el_class=”c-807667″][vc_column_text]30\/03\/2021[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”3\/4″ offset=”vc_col-xs-9″][vc_column_text]Board of Directors meeting to approve unaudited Revenue and key KPI figures for Q1 2021[\/vc_column_text][\/vc_column][vc_column width=”1\/4″ offset=”vc_col-xs-3″ el_class=”c-807667″][vc_column_text]16\/04\/2021[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”3\/4″ offset=”vc_col-xs-9″][vc_column_text]Shareholders’ Meeting to approve the Financial Statements as at\u00a031<\/span>\/12<\/span>\/2020<\/span>[\/vc_column_text][\/vc_column][vc_column width=”1\/4″ offset=”vc_col-xs-3″ el_class=”c-807667″][vc_column_text]30\/04\/2021[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”3\/4″ offset=”vc_col-xs-9″][vc_column_text]Board of Directors’ meeting to approve the unaudited Revenue and key KPI figures for Q2 2021[\/vc_column_text][\/vc_column][vc_column width=”1\/4″ offset=”vc_col-xs-3″ el_class=”c-807667″][vc_column_text]20\/07\/2021[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”3\/4″ offset=”vc_col-xs-9″][vc_column_text]BoD to approve the Half-Yearly Financial Report as at 30 June 2021, voluntarily audited[\/vc_column_text][\/vc_column][vc_column width=”1\/4″ offset=”vc_col-xs-3″ el_class=”c-807667″][vc_column_text]24\/09\/2021[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”3\/4″ offset=”vc_col-xs-9″][vc_column_text]BoD to approve unaudited Revenue and key KPI figures for Q3 2021[\/vc_column_text][\/vc_column][vc_column width=”1\/4″ offset=”vc_col-xs-3″ el_class=”c-807667″][vc_column_text]19\/10\/2021[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n<\/section>","protected":false},"excerpt":{"rendered":"

[vc_row][vc_column][vc_column_text][\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”3\/4″ offset=”vc_col-xs-9″][vc_column_text]BoD to approve revenue figures and main KPIs for Q4 2020, unaudited[\/vc_column_text][\/vc_column][vc_column width=”1\/4″ offset=”vc_col-xs-3″ el_class=”c-807667″][vc_column_text]29\/01\/2021[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”3\/4″ offset=”vc_col-xs-9″][vc_column_text]BoD to approve the draft Financial Statements as at 31\/12\/2020[\/vc_column_text][\/vc_column][vc_column width=”1\/4″ offset=”vc_col-xs-3″ el_class=”c-807667″][vc_column_text]30\/03\/2021[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”3\/4″ offset=”vc_col-xs-9″][vc_column_text]Board of Directors meeting to approve unaudited Revenue and key KPI figures for Q1 2021[\/vc_column_text][\/vc_column][vc_column width=”1\/4″ offset=”vc_col-xs-3″ el_class=”c-807667″][vc_column_text]16\/04\/2021[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”3\/4″ offset=”vc_col-xs-9″][vc_column_text]Shareholders’ Meeting to approve…<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":645,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"page-farmaegroup.php","meta":{"_mi_skip_tracking":false},"yoast_head":"\nFinancial Calendar 2021 - Talea Group S.p.A<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/taleagroupspa.com\/en\/investor-relations\/financial-calendar-2021\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Financial Calendar 2021 - Talea Group S.p.A\" \/>\n<meta property=\"og:description\" content=\"[vc_row][vc_column][vc_column_text][\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”3\/4″ offset=”vc_col-xs-9″][vc_column_text]BoD to approve revenue figures and main KPIs for Q4 2020, unaudited[\/vc_column_text][\/vc_column][vc_column width=”1\/4″ offset=”vc_col-xs-3″ el_class=”c-807667″][vc_column_text]29\/01\/2021[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”3\/4″ offset=”vc_col-xs-9″][vc_column_text]BoD to approve the draft Financial Statements as at 31\/12\/2020[\/vc_column_text][\/vc_column][vc_column width=”1\/4″ offset=”vc_col-xs-3″ el_class=”c-807667″][vc_column_text]30\/03\/2021[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”3\/4″ offset=”vc_col-xs-9″][vc_column_text]Board of Directors meeting to approve unaudited Revenue and key KPI figures for Q1 2021[\/vc_column_text][\/vc_column][vc_column width=”1\/4″ offset=”vc_col-xs-3″ el_class=”c-807667″][vc_column_text]16\/04\/2021[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”3\/4″ offset=”vc_col-xs-9″][vc_column_text]Shareholders’ Meeting to approve…\" \/>\n<meta property=\"og:url\" content=\"https:\/\/taleagroupspa.com\/en\/investor-relations\/financial-calendar-2021\/\" \/>\n<meta property=\"og:site_name\" content=\"Talea Group S.p.A\" \/>\n<meta property=\"article:modified_time\" content=\"2023-02-10T11:46:13+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/taleagroupspa.com\/en\/investor-relations\/financial-calendar-2021\/\",\"url\":\"https:\/\/taleagroupspa.com\/en\/investor-relations\/financial-calendar-2021\/\",\"name\":\"Financial Calendar 2021 - Talea Group S.p.A\",\"isPartOf\":{\"@id\":\"https:\/\/taleagroupspa.com\/en\/#website\"},\"datePublished\":\"2021-01-21T15:22:25+00:00\",\"dateModified\":\"2023-02-10T11:46:13+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/taleagroupspa.com\/en\/investor-relations\/financial-calendar-2021\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/taleagroupspa.com\/en\/investor-relations\/financial-calendar-2021\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/taleagroupspa.com\/en\/investor-relations\/financial-calendar-2021\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/taleagroupspa.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Investor Relations\",\"item\":\"https:\/\/taleagroupspa.com\/en\/investor-relations\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Financial Calendar 2021\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/taleagroupspa.com\/en\/#website\",\"url\":\"https:\/\/taleagroupspa.com\/en\/\",\"name\":\"Talea Group S.p.A\",\"description\":\"Talea Group S.p.A, societ\u00e0 quotata sul mercato Euronext Growth Milan di Borsa Italiana nata dal rebranding di Farma\u00e8 S.p.A., \u00e8 tra i principali gruppi digitali in Europa nel macrosettore multicanale della Salute, Benessere e Bellezza e nei servizi media e di trasformazione digitale per le imprese.\u00a0\",\"publisher\":{\"@id\":\"https:\/\/taleagroupspa.com\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/taleagroupspa.com\/en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/taleagroupspa.com\/en\/#organization\",\"name\":\"Talea Group S.p.A\",\"url\":\"https:\/\/taleagroupspa.com\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/taleagroupspa.com\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/taleagroupspa.com\/wp-content\/uploads\/2022\/09\/logo-dark.svg\",\"contentUrl\":\"https:\/\/taleagroupspa.com\/wp-content\/uploads\/2022\/09\/logo-dark.svg\",\"caption\":\"Talea Group S.p.A\"},\"image\":{\"@id\":\"https:\/\/taleagroupspa.com\/en\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Financial Calendar 2021 - Talea Group S.p.A","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/taleagroupspa.com\/en\/investor-relations\/financial-calendar-2021\/","og_locale":"en_US","og_type":"article","og_title":"Financial Calendar 2021 - Talea Group S.p.A","og_description":"[vc_row][vc_column][vc_column_text][\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”3\/4″ offset=”vc_col-xs-9″][vc_column_text]BoD to approve revenue figures and main KPIs for Q4 2020, unaudited[\/vc_column_text][\/vc_column][vc_column width=”1\/4″ offset=”vc_col-xs-3″ el_class=”c-807667″][vc_column_text]29\/01\/2021[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”3\/4″ offset=”vc_col-xs-9″][vc_column_text]BoD to approve the draft Financial Statements as at 31\/12\/2020[\/vc_column_text][\/vc_column][vc_column width=”1\/4″ offset=”vc_col-xs-3″ el_class=”c-807667″][vc_column_text]30\/03\/2021[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”3\/4″ offset=”vc_col-xs-9″][vc_column_text]Board of Directors meeting to approve unaudited Revenue and key KPI figures for Q1 2021[\/vc_column_text][\/vc_column][vc_column width=”1\/4″ offset=”vc_col-xs-3″ el_class=”c-807667″][vc_column_text]16\/04\/2021[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column width=”3\/4″ offset=”vc_col-xs-9″][vc_column_text]Shareholders’ Meeting to approve…","og_url":"https:\/\/taleagroupspa.com\/en\/investor-relations\/financial-calendar-2021\/","og_site_name":"Talea Group S.p.A","article_modified_time":"2023-02-10T11:46:13+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/taleagroupspa.com\/en\/investor-relations\/financial-calendar-2021\/","url":"https:\/\/taleagroupspa.com\/en\/investor-relations\/financial-calendar-2021\/","name":"Financial Calendar 2021 - Talea Group S.p.A","isPartOf":{"@id":"https:\/\/taleagroupspa.com\/en\/#website"},"datePublished":"2021-01-21T15:22:25+00:00","dateModified":"2023-02-10T11:46:13+00:00","breadcrumb":{"@id":"https:\/\/taleagroupspa.com\/en\/investor-relations\/financial-calendar-2021\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/taleagroupspa.com\/en\/investor-relations\/financial-calendar-2021\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/taleagroupspa.com\/en\/investor-relations\/financial-calendar-2021\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/taleagroupspa.com\/en\/"},{"@type":"ListItem","position":2,"name":"Investor Relations","item":"https:\/\/taleagroupspa.com\/en\/investor-relations\/"},{"@type":"ListItem","position":3,"name":"Financial Calendar 2021"}]},{"@type":"WebSite","@id":"https:\/\/taleagroupspa.com\/en\/#website","url":"https:\/\/taleagroupspa.com\/en\/","name":"Talea Group S.p.A","description":"Talea Group S.p.A, societ\u00e0 quotata sul mercato Euronext Growth Milan di Borsa Italiana nata dal rebranding di Farma\u00e8 S.p.A., \u00e8 tra i principali gruppi digitali in Europa nel macrosettore multicanale della Salute, Benessere e Bellezza e nei servizi media e di trasformazione digitale per le imprese.\u00a0","publisher":{"@id":"https:\/\/taleagroupspa.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/taleagroupspa.com\/en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/taleagroupspa.com\/en\/#organization","name":"Talea Group S.p.A","url":"https:\/\/taleagroupspa.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/taleagroupspa.com\/en\/#\/schema\/logo\/image\/","url":"https:\/\/taleagroupspa.com\/wp-content\/uploads\/2022\/09\/logo-dark.svg","contentUrl":"https:\/\/taleagroupspa.com\/wp-content\/uploads\/2022\/09\/logo-dark.svg","caption":"Talea Group S.p.A"},"image":{"@id":"https:\/\/taleagroupspa.com\/en\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/taleagroupspa.com\/en\/wp-json\/wp\/v2\/pages\/1353"}],"collection":[{"href":"https:\/\/taleagroupspa.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/taleagroupspa.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/taleagroupspa.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/taleagroupspa.com\/en\/wp-json\/wp\/v2\/comments?post=1353"}],"version-history":[{"count":6,"href":"https:\/\/taleagroupspa.com\/en\/wp-json\/wp\/v2\/pages\/1353\/revisions"}],"predecessor-version":[{"id":11053,"href":"https:\/\/taleagroupspa.com\/en\/wp-json\/wp\/v2\/pages\/1353\/revisions\/11053"}],"up":[{"embeddable":true,"href":"https:\/\/taleagroupspa.com\/en\/wp-json\/wp\/v2\/pages\/645"}],"wp:attachment":[{"href":"https:\/\/taleagroupspa.com\/en\/wp-json\/wp\/v2\/media?parent=1353"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}